These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 31702381)

  • 1. A dual functional probe for assessing human CYP450 3A5 and 3A enzymes bioactivities.
    Yan F; Cui Y; An Y; Ning J; Zhao X; Feng L; Huo X; Wang C; Lv C; Ma X; Tian X
    Future Med Chem; 2019 Nov; 11(22):2891-2903. PubMed ID: 31702381
    [No Abstract]   [Full Text] [Related]  

  • 2. A Naturally Occurring Isoform-Specific Probe for Highly Selective and Sensitive Detection of Human Cytochrome P450 3A5.
    Wu JJ; Cao YF; Feng L; He YQ; Hong JY; Dou TY; Wang P; Hao DC; Ge GB; Yang L
    J Med Chem; 2017 May; 60(9):3804-3813. PubMed ID: 28441491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytochrome P450 3A-dependent metabolism of a potent and selective gamma-aminobutyric acid Aalpha2/3 receptor agonist in vitro: involvement of cytochrome P450 3A5 displaying biphasic kinetics.
    Ma B; Polsky-Fisher SL; Vickers S; Cui D; Rodrigues AD
    Drug Metab Dispos; 2007 Aug; 35(8):1301-7. PubMed ID: 17460031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytochrome P450 3A4 and CYP3A5-Catalyzed Bioactivation of Lapatinib.
    Towles JK; Clark RN; Wahlin MD; Uttamsingh V; Rettie AE; Jackson KD
    Drug Metab Dispos; 2016 Oct; 44(10):1584-97. PubMed ID: 27450182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of three CYP3A isoforms to metabolism of R- and S-warfarin.
    Jones DR; Kim SY; Boysen G; Yun CH; Miller GP
    Drug Metab Lett; 2010 Dec; 4(4):213-9. PubMed ID: 20615193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytochrome P450 3A5 is highly expressed in normal prostate cells but absent in prostate cancer.
    Leskelä S; Honrado E; Montero-Conde C; Landa I; Cascón A; Letón R; Talavera P; Cózar JM; Concha A; Robledo M; Rodríguez-Antona C
    Endocr Relat Cancer; 2007 Sep; 14(3):645-54. PubMed ID: 17914095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical significance of cytochrome P450 genetic polymorphism--part IV. Cytochrome P450 3A4 and 3A5].
    Duricová J; Grundmann M
    Ceska Slov Farm; 2011 Dec; 60(6):276-82. PubMed ID: 22312850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of human intestinal wall metabolism by macrolide antibiotics: effect of clarithromycin on cytochrome P450 3A4/5 activity and expression.
    Pinto AG; Wang YH; Chalasani N; Skaar T; Kolwankar D; Gorski JC; Liangpunsakul S; Hamman MA; Arefayene M; Hall SD
    Clin Pharmacol Ther; 2005 Mar; 77(3):178-88. PubMed ID: 15735612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic Profile of 3-Acetyl-11-Keto-β-Boswellic Acid and 11-Keto-β-Boswellic Acid in Human Preparations In Vitro, Species Differences, and Bioactivity Variation.
    Cui Y; Tian X; Ning J; Wang C; Yu Z; Wang Y; Huo X; Jin L; Deng S; Zhang B; Ma X
    AAPS J; 2016 Sep; 18(5):1273-1288. PubMed ID: 27329304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of cytochrome P450 3A4 and 3A5 to the metabolism of atorvastatin.
    Park JE; Kim KB; Bae SK; Moon BS; Liu KH; Shin JG
    Xenobiotica; 2008 Sep; 38(9):1240-51. PubMed ID: 18720283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of CYP3A4*22, CYP3A5*3, and CYP3A combined genotypes on tamoxifen metabolism.
    Sanchez Spitman AB; Moes DJAR; Gelderblom H; Dezentje VO; Swen JJ; Guchelaar HJ
    Eur J Clin Pharmacol; 2017 Dec; 73(12):1589-1598. PubMed ID: 28849250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gomisin A is a Novel Isoform-Specific Probe for the Selective Sensing of Human Cytochrome P450 3A4 in Liver Microsomes and Living Cells.
    Wu JJ; Ge GB; He YQ; Wang P; Dai ZR; Ning J; Hu LH; Yang L
    AAPS J; 2016 Jan; 18(1):134-45. PubMed ID: 26361765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relative role of CYP3A4 and CYP3A5 in eplerenone metabolism.
    McGraw J; Cherney M; Bichler K; Gerhardt A; Nauman M
    Toxicol Lett; 2019 Oct; 315():9-13. PubMed ID: 31408697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism of alfentanil by cytochrome p4503a (cyp3a) enzymes.
    Klees TM; Sheffels P; Dale O; Kharasch ED
    Drug Metab Dispos; 2005 Mar; 33(3):303-11. PubMed ID: 15557344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactivation of Human Cytochrome P450 3A4 and 3A5 by Dronedarone and N-Desbutyl Dronedarone.
    Hong Y; Chia YM; Yeo RH; Venkatesan G; Koh SK; Chai CL; Zhou L; Kojodjojo P; Chan EC
    Mol Pharmacol; 2016 Jan; 89(1):1-13. PubMed ID: 26490246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The exposure of highly toxic aconitine does not significantly impact the activity and expression of cytochrome P450 3A in rats determined by a novel ultra performance liquid chromatography-tandem mass spectrometric method of a specific probe buspirone.
    Zhu L; Yang X; Zhou J; Tang L; Xia B; Hu M; Zhou F; Liu Z
    Food Chem Toxicol; 2013 Jan; 51():396-403. PubMed ID: 23085095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between CYP3A5 genotypes in graft liver and increase in tacrolimus biotransformation from steroid treatment in living-donor liver transplant patients.
    Hosohata K; Uesugi M; Hashi S; Hosokawa M; Inui K; Matsubara K; Ogawa K; Fujimoto Y; Kaido T; Uemoto S; Masuda S
    Drug Metab Pharmacokinet; 2014; 29(1):83-9. PubMed ID: 23955548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of CYP3A5 polymorphism on the pharmacokinetics of psychiatric drugs.
    Ragia G; Dahl ML; Manolopoulos VG
    Curr Drug Metab; 2016; 17(3):227-36. PubMed ID: 26651976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic polymorphisms of the CYP3A4, CYP3A5, CYP3A7 and CYP1A2 among the Jordanian population.
    Salameh G; Al Hadidi K; El Khateeb M
    Environ Toxicol Pharmacol; 2012 Jul; 34(1):23-33. PubMed ID: 22426036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the relationship between expression of cytochrome P450 enzymes and gefitinib pharmacokinetics.
    Swaisland HC; Cantarini MV; Fuhr R; Holt A
    Clin Pharmacokinet; 2006; 45(6):633-44. PubMed ID: 16719544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.